KACEY TOMKO: Open Payments
NPI 1104122233 · MOOSIC, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,164 in 79 payments from 15 companies in 2025. Trend: 2023 $1,449 · 2024 $1,054 · 2025 $1,164
Food & beverage: $1,089Education: $76
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 11 | $190 |
| ABBVIE INC. | 16 | $175 |
| Neurocrine BioSciences, Inc. | 11 | $154 |
| E.R. Squibb & Sons, L.L.C. | 11 | $146 |
| Alkermes, Inc. | 5 | $87 |
| Janssen Pharmaceuticals, Inc | 5 | $81 |
| Vanda Pharmaceuticals Inc. | 3 | $55 |
| Otsuka America Pharmaceutical, Inc. | 3 | $52 |
| Almatica Pharma LLC | 3 | $48 |
| Lundbeck LLC | 3 | $43 |
Products named: VRAYLAR, INGREZZA, COBENFY, REXULTI, AUSTEDO XR, ARISTADA, FANAPT, SPRAVATO.
Industry payments across PA — which companies pay providers there.
